This is the authors' abstract. We don't add key points for this paper.
Herein, Elaeagnus angustifolia L. was utilized as a raw material to extract bound polyphenols using an ultrasound-assisted complex enzyme method for the first time. The effects of enzyme ratio, ultrasonic time, liquid-to-solid ratio, and pH value on the bound polyphenol yield were investigated using single-factor experiments. The key parameters were subsequently optimized using the Box–Behnken design. The optimal conditions identified were as follows: enzyme ratio (α-amylase/cellulase = 5:1 mg/mg), ultrasonic time of 50 min, liquid-to-solid ratio of 12:1 mL/g, and pH value of 5. Under these conditions, the bound polyphenol yield was measured at 13.970 ± 0.3 mg/g. A total of 27 phenolic compounds were identified using ultrahigh-performance liquid chromatography–ion mobility quadrupole time-of-flight mass spectrometry (UPLC–IMS-QTOF-MS), including two coumarins, five lignins, 10 polyphenols, nine flavonoids, and one tannin, and specifically containing Angeloylgomisin Q, Yakuchinone A, Furosin, 6-Dehydrogingerdione, and 4′-Methylpinosylvin, and so on. Antioxidant activity was assessed using the 1,1-diphenyl-2-picryl-hydrazil (DPPH) and 2,2′-azino-bis-(3-ethylbenzthiazoline-6-sulfonate) (ABTS) methods, revealing significant antioxidant potential. This study introduced a novel extraction process for bound polyphenols from E. angustifolia L. and provided the first qualitative analysis of bound polyphenols in this species, establishing a scientific foundation for its development and application in the functional food, medicine, and cosmetics industries.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: